Both in R&D — Physical & Biological Sciences
Incyte Genomics vs Absci
Over the past year INCY returned +11.6% and ABSI returned +146.5%; their daily moves had a correlation of 0.23.
INCY +11.6% ABSI +146.5%Growth of $1, one year, split-adjusted
| Metric | INCY | ABSI |
|---|---|---|
| Price | $118.01 | $9.39 |
| Market cap | $24.05B | $1.61B |
| Today | −3.94% | −10.40% |
| 1 month | +4.0% | +1.8% |
| 6 months | +20.7% | +63.3% |
| Year to date | +19.5% | +169.1% |
| 1 year | +14.7% | +138.3% |
| Revenue growth (YoY) | +14.0% | −46.4% |
| Gross margin | 93.0% | 100.0% |
| Net margin | −50.4% | −10443.4% |
| P/E (TTM) | 59.6× | — |
| Price / sales | 4.0× | 1,032.3× |
| Net cash | $3.82B | $201.0M |
| Dividend yield | — | — |
| Volatility (60d) | 29.8% | 103.2% |
| Short % of float | 5.9% | 31.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).